[Federal Register Volume 61, Number 248 (Tuesday, December 24, 1996)]
[Notices]
[Pages 67853-67854]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-32607]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 2, 1996, Radian 
International LLC, 8501 North Mopac Blvd., P.O. Box 201088, Austin, 
Texas 78720, made application by letter dated October 2, 1996, to the 
Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                            Drug                               Schedule 
------------------------------------------------------------------------
Alpha-Ethyltryptamine (7249)................................          I 
3,4,5-Trimethoxyamphetamine (7390)..........................          I 
4-Bromo-2,5-dimethoxyamphetamine (7391).....................          I 
4-Bromo-2,5-dimethoxyphenethylamine (7392)..................          I 
4-Methyl-2,5-dimethoxyamphetamine (7395)....................          I 
2,5-Dimethoxyamphetamine (7396).............................          I 
2,5-Dimethoxy-4-ethylamphetamine (7399).....................          I 
5-Methoxy-3,4-methylenedioxyamphetamine (7401)..............          I 
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)..............          I 
Bufotenine (7433)...........................................          I 
Codeine-N-oxide (9053)......................................          I 
Heroin (9200)...............................................          I 
Morphine-N-oxide (9307).....................................          I 
Pholcodine (9314)...........................................          I 
Alphamethadol (9605)........................................          I 
Betcetylmethadol (9607).....................................          I 
Betamethadol (9609).........................................          I 
Norlevorphanol (9634).......................................          I 
Para-Fluorofentanyl (9812)..................................          I 
Alpha-methylfentanyl (9814).................................          I 
Acetyl-alpha-methylfentanyl (9815)..........................          I 
Beta-hydroxyfentanyl (9830).................................          I 
Beta-hydroxy-3-methylfentanyl (9831)........................          I 
Alpha-Methylthiofentanyl (9832).............................          I 
3-Methylthiofentanyl (9833).................................          I 
Thiofentanyl (9835).........................................          I 
Phenmetrazine (1631)........................................         II 
Glutethimide (2550).........................................         II 
Cocaine (9041)..............................................         II 
Codeine (9050)..............................................         II 
Levomethorphan (9210).......................................         II 

[[Page 67854]]

                                                                        
Levorphanol (9220)..........................................         II 
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to make deuterated and non-deuterated drug 
reference standards which will be distributed to analytical and 
forensic laboratories for drug testing programs.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. Federal Register Representative (CCR), and must be 
filed no later than February 24, 1997.

    Dated: November 19, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-32607 Filed 12-23-96; 8:45 am]
BILLING CODE 4410-09-M